8-K: Altria Narrows 2026 EPS Guidance, Reports Q2 Results

Altria Group, Inc. announced its second-quarter and first-half 2026 financial results, narrowing its full-year adjusted diluted EPS guidance.

Summary

• Altria Group, Inc. reported its financial results for the second quarter and first half of 2026.
• The company narrowed its full-year 2026 adjusted diluted earnings per share (EPS) guidance to a range of $5.61 to $5.72, representing a growth rate of 3.5% to 5.5% from a 2025 base of $5.42.
• Second-quarter net revenues were $6.111 billion, a slight increase of 0.1% compared to the prior year.
• First-half net revenues increased by 1.6% to $11.539 billion.
• Adjusted diluted EPS for the second quarter increased by 2.8% to $1.48.
• Adjusted diluted EPS for the first half increased by 4.9% to $2.80.
• The company repurchased 0.8 million shares for $55 million in the second quarter and 5.3 million shares for $335 million in the first half.
• Altria paid dividends of $1.8 billion in the second quarter and $3.6 billion in the first half.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive report, with the narrowing of EPS guidance and continued shareholder returns being positive, while declines in core cigarette volumes and oral tobacco present ongoing challenges.

Positives

• Adjusted diluted EPS growth of 4.9% for the first half of 2026.
• Narrowed full-year 2026 adjusted diluted EPS guidance to $5.61-$5.72, raising the lower end of the previous range.
• Returned nearly $3.9 billion to shareholders through dividends and share repurchases in the first half.
• Marlboro Cowboy Cut generated strong interest among premium smokers.
• Basic brand continued to gain traction in the discount segment.
• Reported cigar shipment volume increased 5.0% in the second quarter and 2.6% in the first half.
• on! retail share of the oral tobacco category increased by 0.3 share points year-over-year in Q2.
• The nicotine pouch category grew to 59.9% of the oral tobacco category in Q2.

Negatives

• Reported diluted EPS decreased by 2.8% to $1.37 in the second quarter.
• Smokeable products segment reported domestic cigarette shipment volume decreased by 3.2% in the second quarter.
• Oral tobacco products segment reported domestic shipment volume decreased by 8.5% in the second quarter.
• Marlboro retail share of the total cigarette category decreased by 1.5 share points versus the prior year in Q2.
• on! retail share of the nicotine pouch category decreased by 1.7 share points versus the prior year in Q2.
• Total oral tobacco products retail share decreased by 3.7 share points in Q2.
• Increased capital expenditures expected for 2026, between $375 million and $450 million, up from $300 million to $375 million, primarily for USSTC Facilities Consolidation.
• NJOY ACE is not expected to return to the marketplace in 2026.

Risks

• Moderated e-vapor industry growth impacting combustible and e-vapor product volumes.
• Increased macroeconomic uncertainty affecting adult nicotine consumers (ANCs).
• NJOY ACE not returning to the marketplace in 2026.
• Investments in support of contract manufacturing capabilities.
• Investments in support of the company's Vision.
• Potential for unfavorable outcomes in litigation proceedings or governmental investigations.
• Risks associated with significant federal, state, and local government actions, including FDA regulatory actions.
• Increases in nicotine product-related taxes.

Future Outlook

Altria expects to deliver adjusted diluted EPS in a range of $5.61 to $5.72 for the full year 2026, representing a growth rate of 3.5% to 5.5% from a base of $5.42 in 2025. This guidance accounts for moderated e-vapor industry growth, macroeconomic uncertainty, investments in contract manufacturing, the absence of NJOY ACE, reinvestment of cost savings, and investments in their Vision. Capital expenditures are now projected to be between $375 million and $450 million.

Management Comments

• "In the second quarter, our operating companies continued to deliver against the priorities we outlined at the start of the year advancing our smoke-free portfolio, strengthening our traditional tobacco businesses and delivering significant returns to shareholders," said Sal Mancuso, Altria's Chief Executive Officer.
• "We delivered strong first-half results, driving adjusted diluted EPS growth of 4.9%, and returned nearly $3.9 billion to shareholders through dividends and share repurchases combined."
• "This performance reflects steady, disciplined execution and confidence in our full-year plan, which allowed us to narrow our earnings guidance for the year."
• "We are raising the lower-end of our full-year 2026 guidance."

Industry Context

StockSavvy.ai notes that Altria's results reflect ongoing shifts in the nicotine market, with challenges in traditional cigarette volumes offset by growth in smoke-free alternatives like oral nicotine pouches. The company's strategic focus on 'Moving Beyond Smoking' and investment in its smoke-free portfolio are key themes in this evolving industry landscape.

Comparison to Industry Standards

• No direct comparisons to specific global benchmarks or named competitors were provided in the filing for Q2 or H1 2026 financial performance.
• The filing mentions industry decline rates for cigarettes and growth rates for oral nicotine pouches, indicating a broader market trend rather than a direct company-to-company comparison.

Legal Proceedings

• Charges related to tobacco and health and certain other litigation items were recorded in Q2 and H1 2026.

Stakeholder Impact

• Shareholders are impacted by the narrowed EPS guidance and continued returns through dividends and share repurchases.
• Adult nicotine consumers (ANCs) face increased macroeconomic uncertainty, potentially influencing purchasing behavior towards lower-priced brands.
• Suppliers and distributors may be affected by changes in shipment volumes and manufacturing consolidation plans.

Next Steps

• National expansion of Helix's on! PLUS to 120,000 stores nationwide in the third quarter.
• Additional line extensions for Helix's on! PLUS portfolio in the fourth quarter.
• Consolidating USSTC manufacturing operations.
• Continue to advance data-driven, total portfolio approach for smokeable products.

Key Dates

Recommendation

The company is navigating a challenging industry with declining cigarette volumes but is making progress in its smoke-free transition. The narrowed EPS guidance and consistent shareholder returns are positive, but the ongoing risks and the slow pace of smoke-free growth warrant a cautious 'hold' rating.

Keywords

Altria Group, Tobacco, Nicotine Pouches, Smokeable Products, Oral Tobacco, Earnings Per Share, Guidance, Share Repurchases